DHR Health Institute for Research and Development Recognized as a “Top Performing Site” Once Again

Translate to Spanish or other 102 languages!

THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
THREE-PEAT TEAM: The DHR Health Institute for Research and Development pictured here has been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This is the third consecutive time the Institute has received this prestigious recognition. Courtesy image
- Advertisement -

EDINBURG, Texas – The DHR Health Institute for Research and Development is delighted to announce that it has once again been recognized as a “Top Performing Site” by SWOG (formerly the Southwest Oncology Group), one of the nation’s leading cancer clinical trials networks. This marks the third consecutive time the Institute has received this prestigious distinction.

This recognition highlights the ongoing excellence and impact of the Research Institute as it continues to advance cancer research and improve patient outcomes.

“We are deeply honored and this recognition would not be possible without the assistance of the DHR Health Oncology Institute and the leadership of Dr. Jose Cruz,” said Dr. Scott Lillibridge, executive vice president for the DHR Health Institute for Research and Development.

- Advertisement -

SWOG is a global cancer research community supported by the National Cancer Institute (NCI), and recognition as a “Top Performing Site” signifies exceptional performance in clinical trial enrollment, data quality, and patient care standards.

The DHR Health Institute for Research and Development remains committed to innovation and delivering high-quality research opportunities to all residents of the Rio Grande Valley. They are located at 5323 S. McColl Road in Edinburg. For more information about clinical trials in the areas of liver, obesity, cancer, neurology, oncology and urology, call the Institute at (956) 362-2390.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Dr. Alvaro Restrepo Urges Breast Cancer Survivors to Focus on Health Beyond Treatment

Breast cancer survivorship involves more than completing treatment, according to Dr. Alvaro Restrepo, a medical oncologist and hematologist at Texas Oncology McAllen, who urged patients to focus on physical health, emotional well-being, and long-term medical care.

Texas Oncology Experts Discuss Advances in Breast Cancer Detection, Treatment and Survivorship

Dr. Guillermo Lazo, Dr. Jasmine Gowarty, Dr. Joseph Murray, PhD, Dr. Nurul Wahid, MD, FACP, and Dr. Alvaro Restrepo gather during the October 16, 2026, breast cancer symposium in McAllen, Texas, focused on early detection, advances in treatment, and survivorship. Photo by Mega Doctor News.

STHS Children’s and Spirit Halloween Partner to Support Pediatric Patients

Spirit Halloween stores have partnered with the Auxiliary to South Texas Health System to benefit the Child Life Program at South Texas Health System Children’s. Through the collaboration, shoppers can use a 10% discount coupon at any participating Spirit Halloween store in the Rio Grande Valley, and a portion of the proceeds will support pediatric patients receiving care at the hospital.

STHS Behavioral to Host Webinar on Intensive Outpatient Program Benefits, Nov. 5th

Mental health challenges can affect nearly every aspect of a person’s life, from relationships and careers to the ability to manage everyday responsibilities.
- Advertisement -